Clinical trials
Active, not recruiting Lung Neoplasms trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Merck Sharp & Dohme LLC | 3 |
| Novartis Pharmaceuticals | 2 |
| Regeneron Pharmaceuticals | 2 |
| Arcus Biosciences, Inc. | 1 |
| Ege University | 1 |
| Genmab | 1 |
| Gilead Sciences | 1 |
| Hacettepe University | 1 |
| Hasan Kalyoncu University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 19 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Adenocarcinoma of Lung | 1 |
| Carcinoma | 1 |
| Fatigue | 1 |
| Neoplasm Metastasis | 1 |
| Small Cell Lung Carcinoma | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.